John Paulson A.'s most recent trade in Bausch Health Companies Inc was a trade of 34,721,118 Common Stock, no par value done at an average price of $9 . Disclosure was reported to the exchange on Aug. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bausch Health Companies Inc | John A. Paulson | Director | Purchase of securities on an exchange or from another person at price $ 9.00 per share. | 14 Aug 2025 | 34,721,118 | 70,755,869 (20%) | 9% | 9 | 312,490,062 | Common Stock, no par value |
| Bausch Health Companies Inc | John A. Paulson | Director | Purchase of securities on an exchange or from another person at price $ 6.35 per share. | 11 Aug 2025 | 2,000,000 | 34,791,702 (9%) | 0% | 6.4 | 12,700,000 | Common Stock, no par value |
| Bausch Health Companies Inc | John A. Paulson | Director | Purchase of securities on an exchange or from another person at price $ 6.88 per share. | 11 Aug 2025 | 1,156,640 | 35,948,342 (10%) | 0% | 6.9 | 7,957,683 | Common Stock, no par value |
| Bausch Health Companies Inc | John A. Paulson | Director | Purchase of securities on an exchange or from another person at price $ 7.06 per share. | 11 Aug 2025 | 86,409 | 36,034,751 (10%) | 0% | 7.1 | 610,048 | Common Stock, no par value |
| Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 9,384 | 341,439 (0%) | 0% | 0 | Common Shares, No Par Value | |
| Bausch Health Companies Inc | John A. Paulson | Director | Purchase of securities on an exchange or from another person at price $ 5.94 per share. | 13 Jun 2025 | 3,564,059 | 32,791,702 (9%) | 1% | 5.9 | 21,170,510 | Common Stock, no par value |
| Bausch Health Companies Inc | John A. Paulson | Director | Purchase of securities on an exchange or from another person at price $ 5.24 per share. | 10 Jun 2025 | 1,029,098 | 28,222,267 (8%) | 0% | 5.2 | 5,392,474 | Common Stock, no par value |
| Bausch Health Companies Inc | John A. Paulson | Director | Purchase of securities on an exchange or from another person at price $ 5.47 per share. | 10 Jun 2025 | 1,005,376 | 29,227,643 (8%) | 0% | 5.5 | 5,499,407 | Common Stock, no par value |
| Bausch Health Companies Inc | John A. Paulson | Director | Purchase of securities on an exchange or from another person at price $ 5.05 per share. | 10 Jun 2025 | 754,134 | 27,193,169 (7%) | 0% | 5.1 | 3,808,377 | Common Stock, no par value |
| Bausch Lomb Corp | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 20,338 | 69,965 | - | 0 | Common Shares, No Par Value | |
| Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 54,347 | 332,055 (0%) | 0% | 0 | Common Shares, No Par Value | |
| Acadian Asset Management Inc | John A. Paulson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 7,764 | 23,760 (0%) | 0% | 0 | Common Stock | |
| Acadian Asset Management Inc | John A. Paulson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 7,764 | 0 | - | - | Restricted Stock Units | |
| Acadian Asset Management Inc | John A. Paulson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 5,750 | 5,750 | - | - | Restricted Stock Units | |
| Bausch Lomb Corp | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 11.59 per share. | 01 May 2025 | 1,887 | 49,627 | - | 11.6 | 21,870 | Common Shares, No Par Value |
| Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 6.47 per share. | 31 Mar 2025 | 9,659 | 277,708 (0%) | 0% | 6.5 | 62,494 | Common Shares, No Par Value |
| Bausch Health Companies Inc | John Paulson A. | Director | Grant, award, or other acquisition of securities at price $ 8.06 per share. | 31 Dec 2024 | 7,754 | 268,049 (0%) | 0% | 8.1 | 62,497 | Common Shares, No Par Value |
| Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 8.16 per share. | 30 Sep 2024 | 7,659 | 260,295 (0%) | 0% | 8.2 | 62,497 | Common Shares, No Par Value |
| Bausch Lomb Corp | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 19.29 per share. | 30 Sep 2024 | 1,134 | 48,874 | - | 19.3 | 21,875 | Common Shares, No Par Value |
| Bausch Lomb Corp | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 14,696 | 47,740 | - | 0 | Common Shares, No Par Value | |
| Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 6.97 per share. | 28 Jun 2024 | 8,967 | 252,636 (0%) | 0% | 7.0 | 62,500 | Common Shares, No Par Value |
| Bausch Lomb Corp | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 14.52 per share. | 28 Jun 2024 | 1,506 | 33,044 | - | 14.5 | 21,867 | Common Shares, No Par Value |
| Acadian Asset Management Inc | John A. Paulson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,764 | 7,764 | - | - | Restricted Stock Units | |
| Acadian Asset Management Inc | John A. Paulson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 7,662 | 15,996 (0%) | 0% | 0 | Common Stock | |
| Acadian Asset Management Inc | John A. Paulson | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 7,662 | 0 | - | - | Restricted Stock Units | |
| Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 35,360 | 243,669 (0%) | 0% | 0 | Common Shares, No Par Value | |
| Bausch Health Companies Inc | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 10.61 per share. | 29 Mar 2024 | 5,890 | 208,309 (0%) | 0% | 10.6 | 62,493 | Common Shares, No Par Value |
| Bausch Lomb Corp | John A. Paulson | Director | Grant, award, or other acquisition of securities at price $ 17.30 per share. | 29 Mar 2024 | 1,264 | 31,538 | - | 17.3 | 21,867 | Common Shares, No Par Value |
| Acadian Asset Management Inc | John A. Paulson | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 8,334 | 8,334 | - | - | Restricted Stock Units |